{"id":31245,"date":"2023-01-06T07:30:00","date_gmt":"2023-01-06T06:30:00","guid":{"rendered":"https:\/\/www.transgene.com\/?p=31245"},"modified":"2026-01-06T10:43:27","modified_gmt":"2026-01-06T09:43:27","slug":"transgene-recoit-lautorisation-de-lancer-un-essai-de-phase-i-avec-tg6050-un-virus-oncolytique-innovant-arme-avec-de-lil-12-et-administre-par-voie-intraveineuse","status":"publish","type":"post","link":"https:\/\/www.transgene.com\/fr\/transgene-recoit-lautorisation-de-lancer-un-essai-de-phase-i-avec-tg6050-un-virus-oncolytique-innovant-arme-avec-de-lil-12-et-administre-par-voie-intraveineuse\/","title":{"rendered":"Transgene re\u00e7oit l&rsquo;autorisation de lancer un essai de Phase I avec TG6050, un virus oncolytique innovant arm\u00e9 avec de l&rsquo;IL-12 et administr\u00e9 par voie intraveineuse"},"content":{"rendered":"\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>\n\n\n\n<p class=\"eplus-DVrMbh\"><a href=\"https:\/\/www.transgene.com\/CP.php?f=31245&amp;link=20230106_Transgene_TG6050_Delivir_ANSM_FR.pdf\">Transgene re\u00e7oit l&rsquo;autorisation de lancer un essai clinique de Phase I avec TG6050<\/a><\/p>\n\n\n","protected":false},"excerpt":{"rendered":"<p>\u00a0 \u00a0 Transgene re\u00e7oit l&rsquo;autorisation de lancer un essai clinique de Phase I avec TG6050<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_uag_custom_page_level_css":"","footnotes":""},"categories":[164,11,128,56,169],"tags":[],"class_list":["post-31245","post","type-post","status-publish","format-standard","hentry","category-164","category-press-release-fr","category-dates","category-invirio-fr","category-tg6050_fr","entry"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"post-thumbnail":false},"uagb_author_info":{"display_name":"nh","author_link":"https:\/\/www.transgene.com\/fr\/author\/nh\/"},"uagb_comment_info":0,"uagb_excerpt":"\u00a0 \u00a0 Transgene re\u00e7oit l&rsquo;autorisation de lancer un essai clinique de Phase I avec TG6050","_links":{"self":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/31245","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/comments?post=31245"}],"version-history":[{"count":1,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/31245\/revisions"}],"predecessor-version":[{"id":40132,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/31245\/revisions\/40132"}],"wp:attachment":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/media?parent=31245"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/categories?post=31245"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/tags?post=31245"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}